Knieling, Ferdinand
Lee, Serene
Ntziachristos, Vasilis
Funding for this research was provided by:
Sanofi-Aventis Deutschland (SGZ201912542)
Bayerische Forschungsstiftung (SMART-3D)
Horizon 2020 Framework Programme (101115742-IseeG)
Horizon 2020 Framework Programme (871763 (WINTHER))
Article History
Received: 4 September 2024
Accepted: 9 December 2024
First Online: 27 January 2025
Competing interests
: V.N. is a founder and equity owner of Maurus OY, sThesis GmbH, iThera Medical GmbH, Spear UG and I3 Inc. F.K. is a co-inventor, together with iThera Medical GmbH (Germany), on an EU patent (EP 19 163 304.9) relating to a device and a method for analyzing optoacoustic data, an optoacoustic system and a computer program. F.K. is a member of the advisory board of iThera Medical GmbH (Munich, Germany). F.K. received travel support from iThera Medical GmbH (Germany) and Sanofi Aventis (Germany). F.K. reports lecture fees from Sanofi Genzyme. S.L. declares no competing interests.